Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Addex Therapeutics Ltd    ADXN   CH0029850754

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Swiss Exchange
12/16/2014 12/17/2014 12/18/2014 12/19/2014 12/22/2014 Date
2.31(c) 2.5(c) 2.4(c) 2.39(c) 2.33 Last
16 051 57 011 18 708 61 436 39 941 Volume
-2.12% +8.23% -4.00% -0.42% -2.51% Change
More quotes
Company
Addex Therapeutics Ltd. engages in the discovery and development of oral small molecule drugs.The company uses its proprietary discovery platform to address receptors and other proteins that are undruggable for conventional drug discovery methods, including G-protein coupled receptors, receptor... 
More about the company
Chart ADDEX THERAPEUTICS LTD
Duration : Period :
Addex Therapeutics Ltd Technical Analysis Chart | ADXN | CH0029850754 | 4-Traders
Full-screen chart
Latest news on ADDEX THERAPEUTICS LTD
5d ago ADDEX THERAPEUTICS : Amends mGlu2PAM Collaboration Agreement and Receives USD757..
10/21 ADDEX THERAPEUTICS : and the Charcot-Marie-Tooth Association enter collaboration..
10/21 ADDEX THERAPEUTICS : and the Charcot-Marie-Tooth Association enter collaboration..
09/30 ADDEX THERAPEUTICS : Reports First Half 2014 Financial Results
09/30 ADDEX THERAPEUTICS : Reports First Half 2014 Financial Results
07/10 ADDEX THERAPEUTICS : ADX71441 Positive Results in Preclinical Model of Nicotine ..
06/30 ADDEX THERAPEUTICS : Shareholders Approve All Board Proposals at Annual General ..
04/30 ADDEX THERAPEUTICS : Reports 2013 Financial Results
More news
Sector news
58m ago MONDAY'S ETF MOVERS : Eem, bbh
5h ago PHARMACYCLICS : Announces Update on IMBRUVICA® (ibrutinib) Waldenstrom's macrogl..
1d ago MEDIVATION : takes up $335m Curetech licensing option
More sector news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF